 |
인쇄하기
취소
|
Anti-osteoporosis drugs market being heated
Business sources say that with the new launching of Handok Pharm's Actonel (risedronate), the domestic anti-osteoporosis drugs market has emerged as an arena of fierce competition among several pharmaceutical makers.
Handok Pharm expects to achieve 3.0 billion won in sales this year and plans to increase its sales up to 60.0 billion in sales in the next fiver years.
Actonel, which is th...
Handok Pharm expects to achieve 3.0 billion won in sales this year and plans to increase its sales up to 60.0 billion in sales in the next fiver years.
Actonel, which is th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.